Gabapentin (Neurontin®, Parke-Davis)

American Journal of Hospice and Palliative Medicine

Volumn 14, Issue 6, 1997, Pages 311-312

  Fisher, Karen ^a   McPherson, Mary Lynn ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; ANTICONVULSIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN;

HUMAN; REVIEW;

ACETIC ACIDS; AMINES; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS;

EID: 0031279728     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990919701400610     Document Type: Review

References (10)

1. Neurotonin prescribing information, Parke Davis.
2. Mellick LB, Mellick GA: Successful treatment of reflex sympathetic dystrophy with gabapentin. AM J Emerg Med. 1995;13:96.
3. Mellick G, Seng ML: The use of gabapentin in the treatment of reflex sympathetic dystrophy and a phobic disorder. Am J Pain Management. 1995;5:7-9.
4. Mellick GA, Mellick LB: Gabapentin in the management of reflex sympathetic dystrophy. J Pain and Symptom Management. 1995;10:265-266.
5. Mellick GA, Mellick LB: Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil. 1997;78:98-105.
6. Segal AZ, Rordorf G: Gabapentin as a novel treatment for postherpetic neuralgia. Neurology. 1995;46:1175-1176.
7. Cheville A, et al: Neuropathic pain in radiation myelopathy: A case report. Program Book, American Pain Society (14th annual scientific meeting). Abstract #95823, PageA-115.
8. Rosner H, et al: Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996;12:56-58.
9. Schacter S, Sauter M: Treatment of central pain with gabapentin: Case reports. J Epilepsy. 1996;9:223-226.
10. Rao ML, Clarenbach P, Vahlensieck M, et al: Gabapentin augments whole blood serotonin in healthy young men. J of Neural Transmission. 1988;63:129-134.